IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Nasus Pharma LTD

CUSIP: M7071P109 | 13 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13G/ABalyasny Asset Management L.P.1,169,90910.0%New 5%+ stakeJun 30, 2026No 13F filer matched
13G/ABalyasny Asset Management L.P.1,169,909
10.0% of class · Jun 30, 2026

Institutional Holders — Q3 2026

Caitong International Asset Management Co., Ltd4
0.0% of portfolio›$15
StyleTurnoverLocationFiled
Caitong International Asset Management Co., Ltd
4$150.0%GrowthVery HighHong Kong, South Korea2026-10-29
New 5%+ stake
No 13F filer matched